AMIDEBIO, LLC
US UEI UN9KNR7J6J77 · SME
6public awards
$11.1Mtotal public funding
2026-06-15latest award
State aid awards (6)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-06-15 | $4.3M | Grant | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | Department of Health and Human Services |
| 2024-09-01 | $1.9M | Grant | Dual Agonist Insulins for Treating Diabetics with Impaired Awareness o | Department of Health and Human Services |
| 2022-09-15 | $2.7M | Grant | Long-acting Stable Glucagons for Treatment of Hyperinsulinism | Department of Health and Human Services |
| 2021-03-01 | $300k | Grant | Novel Glucose Responsive Insulin for Improved Treatment of Diabetes | Department of Health and Human Services |
| 2019-09-13 | $1.6M | Grant | Stable Glucagon for Treatment of Hyperinsulinism | Department of Health and Human Services |
| 2017-09-18 | $338k | Grant | Stable Glucagon for Treatment of Hyperinsulinism | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →